Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May;84(5):1412-1415.
doi: 10.1016/j.jaad.2021.02.013. Epub 2021 Feb 10.

COVID-19 in melanoma patients: Results of the Spanish Melanoma Group Registry, GRAVID study

Maria Gonzalez-Cao  1 , Cristina Carrera  2 , Juan Francisco Rodriguez Moreno  3 , Pedro Rodríguez-Jiménez  4 , Mónica Antoñanzas Basa  5 , Rosa Feltes Ochoa  6 , Teresa Puertolas  7 , Eva Muñoz-Couselo  8 , José Luis Manzano  9 , Ivan Marquez-Rodas  10 , Juan Martín-Liberal  11 , Ainara Soria  12 , Pilar Lopez Criado  13 , Almudena Garcia-Castaño  14 , Aram Boada  15 , Pablo Ayala de Miguel  16 , Susana Puig  2 , Guillermo Crespo  17 , Pablo Luna Fra  18 , Cristina Aguayo Zamora  19 , Marta Feito Rodríguez  6 , Lara Valles  20 , Ana Drozdowskyj  21 , Cayetana Maldonado-Seral  22 , Jesús Gardeazabal  23 , Laura Villalobos  24 , Rafael Rosell  25 , Luis Antonio Fernandez-Morales  26 , Alberto Rodrigo  27 , Santiago Viteri  21 , Mariano Provencio  28 , Alfonso Berrocal  29 ; Spanish Melanoma Group (GEM)
Affiliations

COVID-19 in melanoma patients: Results of the Spanish Melanoma Group Registry, GRAVID study

Maria Gonzalez-Cao et al. J Am Acad Dermatol. 2021 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest None disclosed.

Figures

Fig 1
Fig 1
OR Plot showing effect on COVID-19 mortality. OR plot showing effect on COVID-19 mortality. Age over 60 years old and previous cardiovascular disorders increased risk of death due to COVID-19 (OR 11.37, 95% CI 1.37-94.41, P = .024 and OR 4.87, 95% CI 1.25-19.06, P = .022, respectively). Patients with 3 or more co-morbidities had higher risk of death due to COVID-19 (OR 4.00, 95% CI 1.12-14.35, P = .033). Previous diagnose of hypertension or diabetes mellitus did not increased the risk of death (OR 1.24, 95% CI 0.37-4.18, P = .734 and OR 3.20, 95% CI 0.72-14.15, P = .125, respectively). The effect of sex and smoking status were not significant factor for the risk of death due to COVID-19 (OR 2.23, 95% CI 0.54-9.13, P = .266 and OR 1.17, 95% CI 0.34-3.96, P = .805, respectively). BRAF plus MEK inhibitors combination did not increase the mortality risk by COVID-19 (OR 0.53, 95% CI 0.09-2.94, P = .463). Immunotherapy treatment did not increase the risk of death by COVID-19 (OR 0.75, 95% CI 0.19-2.97, P = .682). The effect of advanced stage was not a significant factor for the risk of death by COVID-19 (OR 0.61, 95% CI 0.18-2.03, P = .4184). The effect of a previous melanoma complete surgical resection was not a significant factor for the risk of death due to COVID-19 infection (OR 1.37, 95% CI 0.41-4.56, P = .609). ORs with 95% Wald confidence limits. CI, Confidence interval; OR, odds ratio.
See this image and copyright information in PMC

References

    1. Zhang L., Zhu F., Xie L., et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020;31(7):894–901. - PMC - PubMed
    1. Dai M., Liu D., Liu M., et al. Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov. 2020;10(6):783–791. - PMC - PubMed
    1. Lee L.Y.W., Cazier J.B., Angelis V., et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet. 2020;395(10241):1919–1926. - PMC - PubMed
    1. Kuderer N.M., Choueiri T.K., Shah D.P., et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020;395(10241):1907–1918. - PMC - PubMed
    1. Mehta V., Goel S., Kabarriti R., et al. Case fatality rate of cancer patients with COVID-19 in a New York Hospital System. Cancer Discov. 2020;10(7):935–941. - PMC - PubMed

Publication types

LinkOut - more resources